209 related articles for article (PubMed ID: 31482519)
21. Development of a Liposomal Formulation of Acetyltanshinone IIA for Breast Cancer Therapy.
Wang Q; Luo M; Wei N; Chang A; Luo KQ
Mol Pharm; 2019 Sep; 16(9):3873-3886. PubMed ID: 31389706
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticle-delivered quercetin for cancer therapy.
Men K; Duan X; Wei XW; Gou ML; Huang MJ; Chen LJ; Qian ZY; Wei YQ
Anticancer Agents Med Chem; 2014; 14(6):826-32. PubMed ID: 24851877
[TBL] [Abstract][Full Text] [Related]
23. Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes.
Tang WL; Tang WH; Chen WC; Diako C; Ross CF; Li SD
Mol Pharm; 2017 Jun; 14(6):1969-1979. PubMed ID: 28460165
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment.
Wong MY; Chiu GN
Anticancer Drugs; 2010 Apr; 21(4):401-10. PubMed ID: 20110806
[TBL] [Abstract][Full Text] [Related]
25. Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery.
Singh D; Rawat MS; Semalty A; Semalty M
Curr Drug Discov Technol; 2012 Mar; 9(1):17-24. PubMed ID: 21644920
[TBL] [Abstract][Full Text] [Related]
26. Preparation and optimization of quercetin-loaded liposomes for wound healing, using response surface methodology.
Jangde R; Singh D
Artif Cells Nanomed Biotechnol; 2016; 44(2):635-41. PubMed ID: 25375215
[TBL] [Abstract][Full Text] [Related]
27. Encapsulation of flavonoids in liposomal delivery systems: the case of quercetin, kaempferol and luteolin.
Huang M; Su E; Zheng F; Tan C
Food Funct; 2017 Sep; 8(9):3198-3208. PubMed ID: 28805832
[TBL] [Abstract][Full Text] [Related]
28. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
Lim HJ; Masin D; McIntosh NL; Madden TD; Bally MB
J Pharmacol Exp Ther; 2000 Jan; 292(1):337-45. PubMed ID: 10604968
[TBL] [Abstract][Full Text] [Related]
29. Comparison of quercetin pharmacokinetics following oral supplementation in humans.
Kaushik D; O'Fallon K; Clarkson PM; Dunne CP; Conca KR; Michniak-Kohn B
J Food Sci; 2012 Nov; 77(11):H231-8. PubMed ID: 23094941
[TBL] [Abstract][Full Text] [Related]
30. Drug design strategies that aim to improve the low solubility and poor bioavailability conundrum in quercetin derivatives.
Alizadeh SR; Savadkouhi N; Ebrahimzadeh MA
Expert Opin Drug Discov; 2023; 18(10):1117-1132. PubMed ID: 37515777
[TBL] [Abstract][Full Text] [Related]
31. Liposomes, lipid nanocapsules and smartCrystals®: A comparative study for an effective quercetin delivery to the skin.
Hatahet T; Morille M; Hommoss A; Devoisselle JM; Müller RH; Bégu S
Int J Pharm; 2018 May; 542(1-2):176-185. PubMed ID: 29549014
[TBL] [Abstract][Full Text] [Related]
32. Quercetin-containing self-assemble proliposome preparation and evaluation.
Ren J; Fang Z; Jiang L; Du Q
J Liposome Res; 2017 Dec; 27(4):335-342. PubMed ID: 27667265
[TBL] [Abstract][Full Text] [Related]
33. Drug delivery based pharmacological enhancement and current insights of quercetin with therapeutic potential against oral diseases.
Wang Y; Tao B; Wan Y; Sun Y; Wang L; Sun J; Li C
Biomed Pharmacother; 2020 Aug; 128():110372. PubMed ID: 32521458
[TBL] [Abstract][Full Text] [Related]
34. Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof.
Levacheva I; Samsonova O; Tazina E; Beck-Broichsitter M; Levachev S; Strehlow B; Baryshnikova M; Oborotova N; Baryshnikov A; Bakowsky U
Colloids Surf B Biointerfaces; 2014 Sep; 121():248-56. PubMed ID: 25001189
[TBL] [Abstract][Full Text] [Related]
35. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
[TBL] [Abstract][Full Text] [Related]
36. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, characterization and antioxidant activity copper-quercetin complex.
Bukhari SB; Memon S; Mahroof-Tahir M; Bhanger MI
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1901-6. PubMed ID: 18783981
[TBL] [Abstract][Full Text] [Related]
38. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
Fatma S; Talegaonkar S; Iqbal Z; Panda AK; Negi LM; Goswami DG; Tariq M
Drug Deliv; 2016; 23(2):500-11. PubMed ID: 24937381
[TBL] [Abstract][Full Text] [Related]
39. Study of quercetin-loaded liposomes as potential drug carriers: in vitro evaluation of human complement activation.
Landi-Librandi AP; Chrysostomo TN; Caleiro Seixas Azzolini AE; Marzocchi-Machado CM; de Oliveira CA; Lucisano-Valim YM
J Liposome Res; 2012 Jun; 22(2):89-99. PubMed ID: 22011316
[TBL] [Abstract][Full Text] [Related]
40. Recent Advances in Liposomal Drug Delivery System of Quercetin for Cancer Targeting: A Mechanistic Approach.
Das SS; Hussain A; Verma PRP; Imam SS; Altamimi MA; Alshehri S; Singh SK
Curr Drug Deliv; 2020; 17(10):845-860. PubMed ID: 32294036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
